HRTX earnings: a positive outcome, +11.1%

On February 26, 2026, Heron Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +11.1% in the window around the event. It had already run -15.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.